Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Nasal High Flow Air and Walking Ability in COPD Patients

Tests nasal high flow air during a walking test in adults with COPD.

Plain-language title generated from the registry record
Registry title: Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Key facts

Where
Miami, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Source: NCT06578156, who can take part

Where in United States

  • University of MiamiMiami, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Miami
Trial code
NCT06578156
Record updated
22 June 2026
Original description
This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.Read full original descriptionShow less

Physiologic Effects of Nasal High Flow on Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)

This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.

Inclusion: Able to consent; Age 18 years or older; Diagnosis of COPD; Ability to ambulate without assistance; Use of low-flow nasal cannula ≤ 4 L/min or no supplemental oxygen (O2) at all.

Exclusion: Metal implants in the thoracic regions (pacemakers, Automatic Implantable Cardioverter Defibrillator (AICD), plates, screws, rods, and disc replacements); Hemodynamic instability (resting heart rate > 130/minute, systolic blood pressure of ≤ 90 mmHg or ≥ 180 mmHg); Pregnancy; Being on bedrest; Inability to consent or cooperate with the study; Using of > 4 L/min of supplemental O2 or requiring non-invasive ventilation during the daytime.

ClinicalTrials.gov NCT06578156